Earnings History Data for Inventiva S.A. (IVA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Inventiva S.A.

Inventiva S.A. is a clinical-stage biopharmaceutical company. It is focused on the development of oral small molecule therapies for the treatment of NASH, MPS and other diseases with significant unmet medical need. Inventiva S.A. is based in Daix, France.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
27-03-2024	AH		IVA	Inventiva S.A.	160.11	N/A	-0.40	0.00	Inventiva GAAP EPS of -€2.43, revenue of €17.48M [3/27/2024 4:06 PM]	3.62	-0.20 (-5.24%)	3.70	-0.12 (-3.14%)	2.22 - 5.05	73,204	100,000	9,932
Inventiva GAAP EPS of -€2.43, revenue of €17.48M [3/27/2024 4:06 PM]
28-09-2023	AH		IVA	Inventiva S.A.	181.60	N/A	0.00	0.00	Inventiva GAAP EPS of -€1.31, revenue of €1.9M [9/28/2023 4:28 PM]	4.20	-0.06 (-1.41%)	4.30	0.04 (0.94%)	2.22 - 11.75	1,960	30,000	102
Inventiva GAAP EPS of -€1.31, revenue of €1.9M [9/28/2023 4:28 PM]
29-03-2023	AH	4:10 PM ET (Mar 29)	IVA	Inventiva	170.00	N/A	-0.09	0.00	Inventiva GAAP EPS of -€1.31 misses by €0.02, revenue of €12.18M misses by €0.44M [3/29/2023 4:08 PM]	3.46	-0.29 (-7.85%)	0.0	0.0 (0.00%)	3.40 - 12.15	24,183	20,000	0
Inventiva GAAP EPS of -€1.31 misses by €0.02, revenue of €12.18M misses by €0.44M [3/29/2023 4:08 PM]
22-09-2022	PM	4:10 PM ET (Sep 21)	IVA	Inventiva S.A.	164.11	N/A	0.00	-0.45	Inventiva GAAP EPS of -$0.72, revenue of $67M [9/22/2022 6:26 AM]	4.10	0.17 (4.33%)	4.76	0.83 (21.12%)	3.75 - 15.78	98,013	0	19,022
Inventiva, Sino Biopharm sign licensing pact to develop, commercialize NASH treatment [9/21/2022 5:02 PM] Inventiva GAAP EPS of -$0.72, revenue of $67M [9/22/2022 6:26 AM] Inventiva and Sino Biopharm announce licensing and collaboration agreement to develop and commercialize lanifibranor in Greater China [Sep-21-22 04:40PM] Inventiva reports its 2022 first-half financial results and provides a corporate update [Sep-22-22 02:30AM] Inventiva Inks Licensing Pact With China-Based Sino Biopharm For NASH Candidate In Greater China [Sep-22-22 07:27AM]